Expand ABUS Menu

ABUS Stock Summary and Trading Ideas (Arbutus Biopharma | NASDAQ:ABUS)

Charts for Today's Stock Price and Implied Volatility in Arbutus Biopharma


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ABUS by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Arbutus Biopharma (ABUS) Frequently Asked Questions

What does Arbutus Biopharma do?

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

What symbol and exchange does Arbutus Biopharma stock trade?

Arbutus Biopharma trades on the NASDAQ stock market under the symbol ABUS.

What is Arbutus Biopharma stock price doing today?

As of June 2, 2023, ABUS stock price climbed to $2.58 with 486,892 million shares trading.

What is Arbutus Biopharma's Beta?

ABUS has a beta of 0.51, meaning it tends to be less sensitive to market movements. ABUS has a correlation of 0.05 to the broad based SPY ETF.

How much is Arbutus Biopharma worth?

ABUS has a market cap of $428.62 million. This is considered a Small Cap stock.

How much money does Arbutus Biopharma make?

Last quarter Arbutus Biopharma reported $7 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $657,000 and exceeded earnings estimates by $.04.

What is the highest and lowest price Arbutus Biopharma traded in the last 3 year period?

In the last 3 years, ABUS stock traded as high as $9.02 and as low as $1.60.

What are the top ETFs holding Arbutus Biopharma?

The top ETF exchange traded funds that ABUS belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWN.

Is Arbutus Biopharma (ABUS) a good investment?

ABUS has underperformed the market in the last year with a price return of -2.3% while the SPY ETF gained +4.1%. ABUS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -8.2% and +0.4%, respectively, while the SPY returned +7.9% and +2.2%, respectively.

What is the support and resistance for Arbutus Biopharma (ABUS) stock price?

ABUS support price is $2.44 and resistance is $2.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABUS stock will trade within this expected range on the day.